Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 3 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 30INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 3216Carcinoma, Non-Small-Cell Lung 2729Breast Neoplasms 2551Colorectal Neoplasms 1463Prostatic Neoplasms 1307Neoplasm Metastasis 1301Multiple Myeloma 1112Melanoma 1103Ovarian Neoplasms 1006Lung Neoplasms 945Recurrence 924Leukemia, Myeloid, Acute 879Pancreatic Neoplasms 833Lymphoma, Non-Hodgkin 767Lymphoma 713Stomach Neoplasms 692Carcinoma, Renal Cell 660Carcinoma, Hepatocellular 647Leukemia, Lymphocytic, Chronic, B-Cell 560Squamous Cell Carcinoma of Head and Neck 550Lymphoma, Follicular 515Head and Neck Neoplasms 490Glioblastoma 473Small Cell Lung Carcinoma 447Lymphoma, Large B-Cell, Diffuse 440Triple Negative Breast Neoplasms 436Advanced Solid Tumors 432Leukemia 426Uterine Cervical Neoplasms 420Urinary Bladder Neoplasms 405

Interventions

soybean oil, phospholipid emulsion 3fish oil triglycerides 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Hyperphagia × Clear all
NCT04555044 2023-12-27

Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion (Part A)

Baxter Healthcare Corporation

Phase 4 Completed
101 enrolled 29 charts

Pena Shokeir syndrome, type 1, Hyperphagia, Short Bowel Syndrome

NCT02476994 2021-07-21

Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion

Baxter Healthcare Corporation

Phase 4 Terminated
1 enrolled 4 charts

Pena Shokeir syndrome, type 1, Hyperphagia, Short Bowel Syndrome

NCT00292279 2008-05-14

The Impact of Omega-3 Fat Emulsion on Clinical Outcome of Post-Operative Cancer Patients

Fresenius Kabi Sino-Swed Pharmaceutical Corp. Ltd

Phase 3 Completed
206 enrolled

Hyperphagia

NCT00247338 2008-05-12

The Impact of Low Calorie and Low Nitrogen Parenteral Nutrition Support on the Clinical Outcome of Postoperative Patients

Fresenius Kabi Sino-Swed Pharmaceutical Corp. Ltd

Phase 4 Completed
120 enrolled
Gastrointestinal

Gastrointestinal Diseases, Gastrointestinal Neoplasms, Hyperphagia, Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon âš¡